Free Trial
→ This red-hot crypto opportunity could slam shut soon (From Wealthpin Pro) (Ad) Free ELDN Stock Alerts

Eledon Pharmaceuticals (ELDN) SEC Filings & 10K Form

Eledon Pharmaceuticals logo
$4.02 -0.01 (-0.25%)
As of 01/17/2025 04:00 PM Eastern
Compare

Recent Eledon Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Kirk Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Robinson James A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Lee June (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Katkin Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
McBride John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Hillson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
7:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:51 PM		ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:17 PM		Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/05/2024
10:44 AM		Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SC 13G
10/31/2024
4:52 PM		BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:49 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
4:50 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/30/2024
5:36 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/30/2024
5:24 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/29/2024
8:27 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
11:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
09/20/2024
4:00 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:16 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/19/2024
3:33 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q/A
08/19/2024
3:36 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K/A
08/14/2024
4:12 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form NT 10-Q
08/14/2024
4:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:47 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:41 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
11:15 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
05/24/2024
3:02 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/22/2024
6:36 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
05/15/2024
6:00 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This Could be the Biggest AI Winner Under Trump (NOT Nvidia) (Ad)

Forget Nvidia. Legendary investor Louis Navellier is recommending this little-known company because it's helping develop the next generation of Artificial Intelligence... Which has been called "the real game-changer."

Click here now to get the details...
05/13/2024
4:04 PM		BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:15 AM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM		Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:35 PM		ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ELDN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Stunning Trump Exec Order Leaked
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode in 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...
Weiss Ratings | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...
Crypto Swap Profits | Sponsored
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored
Elon’s New AI Firm REVEALED
Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...
Paradigm Press | Sponsored